In KRAS-mutant LUAD with LKB1 inactivation, the expression of GLS1, an enzyme responsible for metabolizing Gln to Glu, was significantly higher compared to KRAS-mutant NSCLC with co-inactivation of LKB1 and KEAP1. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.